1. Cholesterol in remnant-lipoproteins as measured by different methods. Issue 1 (July 2015) Authors: Toth, P.P.; Bays, H.E.; Brown, W.V.; Tomassini, J.E.; Wang, Y.; Polis, A.B.; Tershakovec, A.M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cholesterol in remnant-lipoproteins as measured by different methods. Issue 1 (July 2015) Authors: Toth, P.P.; Bays, H.E.; Brown, W.V.; Tomassini, J.E.; Wang, Y.; Polis, A.B.; Tershakovec, A.M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of armolipid Plus®: An updated prisma compliant systematic review and meta-analysis. (August 2021) Authors: Cicero, A.F.G.; Kennedy, C.; Toth, P.P.; Kneževi'c, T.; Georges, C.M.G.; Šatrauskiene, A.; Fogacci, F. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of inclisiran: A systematic review and pooled analysis of available clinical studies. (August 2021) Authors: Cicero, A.F.G.; Fogacci, F.; Zambon, A.; Toth, P.P.; Borghi, C. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ezetimibe does not increase fasting glucose levels more than statins alone in non-diabetic, hypercholesterolemic patients. Issue 1 (July 2015) Authors: Toth, P.P.; Catapano, A.; Farnier, M.; Foody, J.; Tomassini, J.E.; Jensen, E.; Polis, A.B.; Musliner, T.; Tershakovec, A.M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ezetimibe does not increase fasting glucose levels more than statins alone in non-diabetic, hypercholesterolemic patients. Issue 1 (July 2015) Authors: Toth, P.P.; Catapano, A.; Farnier, M.; Foody, J.; Tomassini, J.E.; Jensen, E.; Polis, A.B.; Musliner, T.; Tershakovec, A.M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of lomitapide and lomitapide/ezetimibe combination therapy on low-density lipoprotein subfractions and risk marker ratios. Issue 1 (July 2015) Authors: Toth, P.P.; Case, D.; Joshi, P.; Jones, S.R.; Martin, S.S. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of lomitapide and lomitapide/ezetimibe combination therapy on low-density lipoprotein subfractions and risk marker ratios. Issue 1 (July 2015) Authors: Toth, P.P.; Case, D.; Joshi, P.; Jones, S.R.; Martin, S.S. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗